Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Research Article

An UHPLC-UV Method for the Determination of Vancomycin in Human Serum

Author(s): Fang Fang, Ning Li, Chunli Xu, Rong Tan, Jihong Yang* and Zhichang Zheng*

Volume 17, Issue 7, 2021

Published on: 19 May, 2020

Page: [847 - 852] Pages: 6

DOI: 10.2174/1573412916999200519140258

Price: $65

Abstract

Objective: To develop a rapid ultra-performance liquid chromatographic (UHPLC)-UV method for vancomycin determination in human serum for therapeutic drug monitoring (TDM).

Methods: Human serum samples were precipitated with 10% perchloric acid, and the supernatant after centrifugation was analyzed on an ACQUITY UHPLC BEH C18 column (2.1 × 50mm, 1.7 μm) via gradient elution with a flow rate at 0.3 mL/min. The mobile phase consisted of acetonitrile and 0.005M KH2PO4 buffer (containing 0.1% triethylamine, pH 3.4). The detection wavelength was set at 210 nm, and the column temperature was set at 40°C. The total runtime was 6.0 min per analysis.

Results: After comprehensive validation, the method was applied to determine the concentration of vancomycin in human serum. The chromatographic peaks of vancomycin and internal standard were not interfered by endogenous matrices. The Retention Time (RT) of vancomycin was 1.91 min, while the internal standard was 1.58 min. The good linearity range of vancomycin concentration was 2.5-120 μg/mL (R2>0.999). The lower Limit of Quantitation (LLOQ) was 2.5 μg/mL. The precision at three Quality Control (QC) levels (including LLOQ) was restricted within 85-115%. The extraction recovery rate of QC samples (4.0, 20.0, and 60.0 μg/mL) were 101.16%, 97.70%, and 94.90%, respectively. Inter- and intra-day precision was less than 8% (RSD). Stability tests under different storage conditions were satisfactory. In patients, the concentration of vancomycin ranged from 7.30 to 89.12 μg/mL determined by the fully validated method.

Conclusion: The rapid sample pre-treatment procedures and short analysis time made this UHPLC-UV method suitable for therapeutic drug monitoring (TDM) of vancomycin.

Keywords: Vancomycin, ultra-performance liquid chromatographic (UHPLC), therapeutic drug monitoring, MRSA, MRSE, infection.

Graphical Abstract
[1]
Aliberti, S.; Reyes, L.F.; Faverio, P.; Sotgiu, G.; Dore, S.; Rodriguez, A.H.; Soni, N.J.; Restrepo, M.I. GLIMP investigators. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect. Dis., 2016, 16(12), 1364-1376.
[http://dx.doi.org/10.1016/S1473-3099(16)30267-5] [PMID: 27593581]
[2]
Bijleveld, Y.; de Haan, T.; Toersche, J.; Jorjani, S.; van der Lee, J.; Groenendaal, F.; Dijk, P.; van Heijst, A.; Gavilanes, A.W.; de Jonge, R.; Dijkman, K.P.; van Straaten, H.; Rijken, M.; Zonnenberg, I.; Cools, F.; Nuytemans, D.; Mathôt, R. A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography/tandem mass spectrometry and its applicability to a clinical study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 951-952, 110-118.
[http://dx.doi.org/10.1016/j.jchromb.2014.01.035] [PMID: 24548921]
[3]
Chahbouni, A.; den Dungen, F.A.V.; Vos, R.M.; den Burger, J.C.; Sinjewel, A.; Wilhelm, A.J.; Veldkamp, A.I.; Swart, E.L.; van Weissenbruch, M.M. An UPLC-MS detection method for the quantification of five antibiotics in human plasma. Bioanalysis, 2015, 7(18), 2321-2329.
[http://dx.doi.org/10.4155/bio.15.121] [PMID: 26417882]
[4]
Oyaert, M.; Peersman, N.; Kieffer, D.; Deiteren, K.; Smits, A.; Allegaert, K.; Spriet, I.; Van Eldere, J.; Verhaegen, J.; Vermeersch, P.; Pauwels, S. Novel LC-MS/MS method for plasma vancomycin: comparison with immunoassays and clinical impact. Clin. Chim. Acta, 2015, 441, 63-70.
[http://dx.doi.org/10.1016/j.cca.2014.12.012] [PMID: 25523192]
[5]
Barco, S.; Castagnola, E.; Gennai, I.; Barbagallo, L.; Loy, A.; Tripodi, G.; Cangemi, G. Ultra high performance liquid chromatography-tandem mass spectrometry vs. commercial immunoassay for determination of vancomycin plasma concentration in children. Possible implications for everyday clinical practice. J. Chemother., 2016, 28(5), 395-402.
[http://dx.doi.org/10.1080/1120009X.2016.1157947] [PMID: 27238431]
[6]
Cao, Y.; Yu, J.; Chen, Y.; Zhang, J.; Wu, X.; Zhang, Y.; Li, G. Development and validation of a new ultra-performance liquid chromatographic method for vancomycin assay in serum and its application to therapeutic drug monitoring. Ther. Drug Monit., 2014, 36(2), 175-181.
[http://dx.doi.org/10.1097/FTD.0b013e3182a458bc] [PMID: 24216537]
[7]
Wilson, J.F.; Davis, A.C.; Tobin, C.M. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment. J. Antimicrob. Chemother., 2003, 52(1), 78-82.
[http://dx.doi.org/10.1093/jac/dkg296] [PMID: 12805260]
[8]
Tsai, I.L.; Sun, H.Y.; Chen, G.Y.; Lin, S.W.; Kuo, C.H. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry. Talanta, 2013, 116, 593-603.
[http://dx.doi.org/10.1016/j.talanta.2013.07.043] [PMID: 24148450]
[9]
Baranowska, I.; Wilczek, A.; Baranowski, J. Rapid UHPLC method for simultaneous determination of vancomycin, terbinafine, spironolactone, furosemide and their metabolites: application to human plasma and urine. Anal. Sci., 2010, 26(7), 755-759.
[http://dx.doi.org/10.2116/analsci.26.755] [PMID: 20631435]
[10]
Sakamoto, Y.; Jinno, Y.; Shinodzuka, I.; Iwasaki, Y.; Ito, R.; Saito, K. Sample cleanup using solid-phase dispersive extraction for determination of vancomycin in serum. Anal. Sci., 2014, 30(2), 271-275.
[http://dx.doi.org/10.2116/analsci.30.271] [PMID: 24521915]
[11]
Sakamoto, Y.; Jinno, Y.; Shinodzuka, I.; Iwasaki, Y.; Ito, R.; Saito, K. Simultaneous determination of most prescribed antibiotics in multiple urban wastewater by SPE-LC-MS/MS. J. Chromatogr. B, 2014, 969, 162-170.
[http://dx.doi.org/10.2116/analsci.30.271] [PMID: 24521915]
[12]
US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, 2001.
[13]
European Medicines Agency Guideline on Bioanalytical Method Validation, 2012.
[14]
Hagihara, M.; Sutherland, C.; Nicolau, D.P. Development of HPLC methods for the determination of vancomycin in human plasma, mouse serum and bronchoalveolar lavage fluid. J. Chromatogr. Sci., 2013, 51(3), 201-207.
[http://dx.doi.org/10.1093/chromsci/bms128] [PMID: 22851425]
[15]
Rybak, M.J.; Lomaestro, B.M.; Rotschafer, J.C.; Moellering, R.C.; Craig, W.A.; Billeter, M.; Dalovisio, J.R.; Levine, D.P. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin. Infect. Dis., 2009, 49(3), 325-327.
[http://dx.doi.org/10.1086/600877] [PMID: 19569969]
[16]
Ye, Z.K.; Chen, Y.L.; Chen, K.; Zhang, X.L.; Du, G.H.; He, B.; Li, D.K.; Liu, Y.N.; Yang, K.H.; Zhang, Y.Y.; Zhai, S.D. Guideline steering group, the guideline development group and the guideline secretary group. therapeutic drug monitoring of vancomycin: a guideline of the division of therapeutic drug monitoring. J. Antimicrob. Chemother., 2016, 71(11), 3020-3025.
[http://dx.doi.org/10.1093/jac/dkw254] [PMID: 27494905]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy